Journey Medical Corp
DERM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867066
No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Journey Medical Corp as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +14 vs. Q3 2021
- Shares held
- 1.63M
- +1.63M vs. Q3 2021
- Total value
- $8.76M
- +$8.76M vs. Q3 2021
- New holders
- 14
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DERM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 71 | $75.2M |
| Q1 2026 | 72 | $55.8M |
| Q4 2025 | 77 | $85.0M |
| Q3 2025 | 68 | $61.9M |
| Q2 2025 | 56 | $46.6M |
| Q1 2025 | 38 | $29.6M |
| Q4 2024 | 37 | $14.8M |
| Q3 2024 | 36 | $12.2M |
| Q2 2024 | 35 | $13.3M |
| Q1 2024 | 33 | $6.68M |
| Q4 2023 | 36 | $7.80M |
| Q3 2023 | 21 | $5.85M |
| Q2 2023 | 20 | $2.63M |
| Q1 2023 | 17 | $2.62M |
| Q4 2022 | 18 | $5.13M |
| Q3 2022 | 20 | $4.62M |
| Q2 2022 | 13 | $6.52M |
| Q1 2022 | 14 | $7.94M |
| Q4 2021 | 14 | $8.76M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Journey Medical Corp; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| B. Riley Financial, Inc. | 864,695 | $4.65M | 0.52% | +864,695 | New |
| Neuberger Berman Group LLC | 199,112 | $1.07M | 0.00% | +199,112 | New |
| American Financial Group Inc | 180,000 | $968.0K | 0.27% | +180,000 | New |
| Perkins Capital Management Inc | 140,800 | $758.0K | 0.51% | +140,800 | New |
| Millrace Asset Group, Inc. | 113,862 | $613.0K | 0.36% | +113,862 | New |
| Cannell Capital LLC | 41,108 | $221.0K | 0.04% | +41,108 | New |
| Goldman Sachs Group Inc | 35,820 | $193.0K | 0.00% | +35,820 | New |
| B. Riley Wealth Management, Inc. | 15,000 | $81.0K | 0.01% | +15,000 | New |
| Citadel Advisors LLC | 10,761 | $58.0K | 0.00% | +10,761 | New |
| Tudor Investment Corp Et Al | 10,602 | $57.0K | 0.00% | +10,602 | New |
| BlackRock Inc. | 9,328 | $50.0K | 0.00% | +9,328 | New |
| UBS Group AG | 3,248 | $17.0K | 0.00% | +3,248 | New |
| Royal Bank of Canada | 2,500 | $13.0K | 0.00% | +2,500 | New |
| Tower Research Capital LLC (TRC) | 656 | $4.00K | 0.00% | +656 | New |